NewsRx

Search our medical news database

Alimentation COUCHE-TARD INC.

Couche-Tard Launches its New Share Repurchase Program

Published in Law and Health Weekly, August 22nd, 2009

Alimentation Couche-Tard Inc. announced that The Toronto Stock Exchange has approved its share repurchase program (the "program"), authorizing the Company to repurchase up to 2,685,370 Class A multiple voting shares (representing 5 % of the 53,707,412 Class A multiple voting shares issued and outstanding) and 12,857,284 Class B subordinate voting shares (representing 10 % of the 128,572,846 Class B subordinate voting shares of the public float) as at July 24, 2009. The net average daily trading volume for the 6-month period preceding July 24, 2009 represents 853 Class A multiple voting shares and 430,871 Class B subordinate voting share. In accordance with the Toronto Stock Exchange...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook